01059na  a2200241   4500001001300000005001500013008004100028024002700069035001800096035002700114100002200141370004800163372004000211372002300251373004200274374004800316375001100364377002200375400002600397400002500423670031500448670005400763KAC20174946420221103104227170921 b aznnnaabn          fa aaa      7 a00000004634382372isni  a(KRI)10966174  a(KISTI)ADPER68010123491 a안희준,d1976-  c한국(국명)[韓國]0KSH20000101452nlsh  a내과[內科]0KSH19990172632nlsh  a혈액종양내과  a울산대학교 의학과 (부교수)  a교수(대학)[敎授]0KSH19980114932nlsh  a남성  l한국어l영어1 aAhn, Heuijune,d1976-1 aAhn, Heejoon,d1976-  aA randomized, open-label, phase ii study comparing pemetrexed plus cisplatin followed by maintenance pemetrexed versus pemetrexed alone in patients with epidermal growth factor receptor (egfr)-mutant non-small cell lung cancer after failure of first-line egfr tyrosine kinase inhibitor, (대한암학회), 2019  a한국연구자정보(KRI)uhttps://www.kri.go.kr